Oncotelic Therapeutics Inc. (OTLC)

Market is closed

Insider Trading: Purchases

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Trieu Large Shareholder, Officer, Director	$0.05	100,000	$4,500.00	90,917,329	2023-05-02	Filing
Trieu Large Shareholder, Officer, Director	$0.05	120,000	$6,000.00	90,558,021	2022-12-06	Filing
Trieu Large Shareholder, Officer, Director	$0.08	70,000	$5,600.00	90,438,021	2022-11-22	Filing
Trieu Large Shareholder, Officer, Director	$0.07	20,000	$1,360.00	90,368,021	2022-09-26	Filing
Trieu Large Shareholder, Officer, Director	$0.08	80,000	$6,560.00	90,348,021	2022-08-25	Filing
Shah Officer	$0.19	8,220	$1,561.80	60,000	2020-11-24	Filing
Shah Officer	$0.19	20,088	$3,816.72	51,780	2020-11-23	Filing
Shah Officer	$0.20	31,692	$6,179.94	31,692	2020-11-20	Filing
Park Officer	$0.18	22,173	$4,097.57	2,833,992	2020-11-19	Filing
Trieu Officer	$0.19	50,500	$9,595.00	15,812,308	2020-11-19	Filing
Trieu	$0.12	3,000	$360.00	15,761,808	2020-03-26	Filing
Reynolds Director	$0.00	250,000	$0.00	280,000	2018-04-12	Filing
Schwieterman Officer, Director	$0.00	625,000	$0.00	625,747	2018-04-12	Filing
Loar Officer	$0.00	250,000	$0.00	300,000	2018-04-12	Filing
Reynolds Director	$0.36	9,950	$3,532.25	30,000	2016-12-16	Filing
Reynolds Director	$0.35	7,350	$2,572.50	20,050	2016-12-16	Filing
Reynolds Director	$0.34	12,700	$4,318.00	12,700	2016-12-16	Filing
Langecker Officer, Director	$2.75	3,000	$8,250.00	5,000	2013-06-28	Filing
Langecker Officer, Director	$2.79	2,000	$5,572.00	2,000	2013-06-25	Filing